Hercules Capital Inc（HTGC）のニュースとイベントHTGCHercules Capital Inc

Rocket Pharmaceuticals Enters $150 Million Credit Facility with Hercules Capital

Rocket Pharmaceuticals (RCKT) "announced that it has entered into a credit facility agreement with Hercules Capital (HTGC) for up to $150 million. The facility strengthens Rocket's financial position and provides access to additional capital to support execution of its pivotal Phase 2 study of RP-A501 for Danon disease and continued advancement of its broader cardiovascular pipeline."

NorthStar Medical Technologies Signs Up to $185M Growth Capital Facility with Hercules Capital

NorthStar Medical Technologies announced a multi-year growth capital facility of up to $185M with Hercules Capital to support NorthStar's continued growth and expansion. The financing, including $100M upfront, will accelerate investment in isotope production and in clinical and commercial drug manufacturing capabilities, enabling NorthStar's pharmaceutical and biotechnology partners to advance next-generation precision cancer therapies to patients worldwide. The agreement supports NorthStar's continued commercial scale-up investment leveraging its industry-leading scientific talent and vertically integrated radiopharmaceutical campus, where it provides clinical and commercial isotope production and radiopharmaceutical manufacturing, including comprehensive cGMP services through its state-of-the-art CDMO.

Hercules Capital Reports Q2 NII of 50c, Beating Consensus of 48c

Hercules Capital reports Q2 NII 50c, consensus 48c